See Who Attended in 2021

120 Capital
2XIdeas
Absci
Accelerated Biosciences Corp.
Actinium Pharmaceuticals, Inc.
Adjuvance Technologies
Adze Biotechnology
Aegis Capital
AffaMed Therapeutics
Affinity Growth Advisors
AffyImmune Therapeutics, Inc.
Agent Capital
Agenus
AIM Medical Robotics
Aisling Capital
Akili Interactive Labs, Inc.
Akttyva Therapeutics, Inc.
Alentia Therapeutics, Inc
Allele Capital Partners
Alpha Blue Ocean
Alphageneron Pharmaceuticals, Inc.
Alta Capital KG
Altium Capital
Altoida, Inc.
Alykomed Global Solutions LLC
Alzheimer’s Drug Discovery Foundation
AMR Action Fund
AnHeart Therapeutics
Anzu Partners
Aqua Partners LLC
Aristar Capital
Array Ventures
Artiman Ventures
Asahi Kasei
Ascella Biosystems
Ashvattha Therapeutics
Aspect Biosystems
Astellas Rx+Business Accelerator
Astellas Venture Management LLC
Astute Capital
atai Life Sciences
Ataraxia Capital Partners
ATEM Capital Fund LP
Athyrium LP
Atinum Investment
Atlas Advisors LLC
Aurora Capital
Barbara Ryan Advisors
Basel Area
Bastion Health
BehaVR
Benchmark Company
Benjamin LLP
Bilayer Therapeutics, Inc.
BIMA Capital
BioCentury Inc
Biocom California
BioConfidant Sàrl
Biogen
BioHealth Capital Fund
BioMap
BioProgress
Bios Partners
BioSpace
BioStrategy LLC
Biotechnology Innovation Organization (BIO)
BioWorld (Clarivate)
Bloomberg
Boehringer Ingelheim Venture Fund
Brain Mapping Foundation
Breakout Ventures
Broadview Ventures
BTIG
C14 Consulting Group
Canaan Partners
Cancer Research Institute
CareDx
Caring Cross
Carpe Biosciences
Casdin Capital, LLC
Cassel Salpeter, LLC
Castor EDC
Catalytic Impact Foundation
Caxton Alternative Management
CBT Advisors
Cellino
Cello Health BioConsulting
Celularity
CG Oncology
CGLife
Children’s Hospital of Philadelphia
China Grand Inc
CINDE – Costa Rican Investment Promotion Agency
Ciscovery Bio Inc
ClearCure Biosciences, Inc
CLINICA DE LA COSTA LTDA

Coast BioVentures LLC
CognifiSense, Inc.
Cognito Therapeutics
Cognoptix
Collaborative Drug Discovery (CDD), Inc.
COMPASS Pathways
ConcertoCare HQ
Content Carnivores, LLC
Context Therapeutics
Covington & Burling LLP
CT Innovations
CTI Life Sciences
CUORiPS Inc.
Cybin Inc.
Daiichi Sankyo Inc.
Debiopharm Innovation Fund SA
Deerfield Management Co
Delos Capital
DHVC
Digital Diagnostics
DigiTx Partners
Diviner
DNA Capital
DNA Consulting
Docbot, Inc.
Doloromics
Double u fund
DoubleRainbow Biosciences
DR Capital
Duce Management
Duke University School of Medicine
eCoast Angels
EcoR1 Capital, LLC
eisnerAmper
Eli Lilly & Company
Encellin
Endpoints News
Esperante
Euclidean Life Science Advisors, LLC
Evercore ISI
Evolution Life Sciences Partners
Faeth Therapeutics
FC Capital Management
Fe Pharmaceuticals, Inc.
Feinberg Consulting; contributing to PR Newswire for Journalists
Feldan Therapeutics
FierceBiotech
Florica Therapeutics
Foothill Ventures
Fountain Healthcare Partners
FreeMind Group
Gaingels
Gateway Health / RSP Systems
GC Therapeutics
GEM
Gemseki Ventures LP
GeneOnline
Genomic Expression Inc
Genprex, Inc.
GG Life Ventures, LLC
Gilder Gagnon Howe & Co
Globalhealthimpactfund
Glooko, Inc.
Golden Seeds
Goldman Sachs Group, Inc
Good Health Capital (New York)
GreenSky Capital
Hatch Biofund Management LLC
Hatch Therapeutics, Inc
HatchBIo Fund/PA Biotechnology Center
Health Innovation for People, Inc
Health Tech Capital
Healthcare Angels
Helicase Venture
HINDUJA GROUP
Horizon Technology Finance
HTH Srl
Humanest
Iaso Ventures
iFocus Health Inc
Ilya Pharma
I-Mab Biopharma
Imec XPAND
Immunicom
IN8bio, Inc.
Individual
Informa
Informa Pharma Intelligence
ingalls & snyder LLC
Insight Partners
InterVenn
INZA Group
IPF Partners
Ipsen Bioscience
ISAR Capital Partners
Italian Angels for Growth
J.P.Morgan
Jazz Phamaceuticals

Jefferies
Johnson & Johnson
Johnson & Johnson Innovation
Joyance Partners
JT Pharma
KEEP Labs Inc.
KKH Advisors
KOFA healthcare
KSJC Consulting Inc.
KYBORA
KYTO tech
Kyto Technology and Life Science Inc
Landmark Family Office/Landmark Angels
Landos Biopharma
Laurel Venture Capital
LaVoieHealthScience
Leveragen, Inc.
LexaGene
Lightship
Lobe Sciences Ltd.
Lumira Ventures
Lyfe Capital
Lyndra Therapeutics
Lynx Capital HK Limited
Marathon Asset Management
Matrix Capital Management
MC Services
McDermott Will & Emery
Medical Excellence Capital
MedRhythms
MedTech Strategist
Merck
Mercy BioAnalytics Inc.
Methuselah Fund
Meyers Investments Family LP
MICHBIO
Micron Biomedical
Mid Atlantic Bio Angels
Mid-Atlantic Group Angel Funds, LP
Mira Life Science Ventures
Miravo HealthCare
MNM Bioscience Inc
Modality.ai
Molecular Health GmbH
MSQ Ventures
Multiomic Advisory Services
Music Beats Cancer
MVM Partners
Mymee
Mythic Therapeutics
NAKI Therapeutics
Nature Biotechnology/Springer Nature
NCL Technology Ventures Ltd.
Neumentum Inc.
New Enterprise Associates
New Frontier Mobile Diagnostics
New Harbor Venture Partners
New Rhein Healthcare Investors
New York Angels
New York City Economic Development Corporation
Newmark
NewYorkBio
Niraxx
No Patient Left Behind
Nodes Advisors AG
North Carolina Biotechnology Center
Northlea Partners LLLP
Northpond Ventures, LP
Novotech
NSIP LLC
NYU Langone Health
NYU School of Medicine
OCA Ventures
Ocean Road Advisors Inc.
Ochre Bio
Omixon
Omniscient Neurotechnology
Oncoustics AI
Ono Venture Investment
Oppenheimer &Co.
Opportunities New Brunswick
Optina Diagnostics
Oracle
Orange Grove Bio
Ordaos Bio
ORI Capital
Origami Therapeutics, Inc.
Osmind
Otsuka Digital
Ovid Therapeutics Inc.
Palo Santo Fund
Panacea Venture
Pappas Capital
Particular Ventures LLC
Pathway Bioventures
Pepper Bio
Pharma Partners
PharmaAcuity

PharmaCatalyst
PharmaVOICE
Phoenix Venture Partners (PVP)
Pii
Pillar Biosciences
Pipeline Therapeutics, Inc.
Plakous Therapeutics, Inc.
PMM/ventureintellengence
PPD Biotech
PPD, Development, L.P.
Prasco
Precirix
Premier Applied Sciences
Prevail Partners LLC
Primera Analytical/Xihua Pharma Shanghai
Psilocybin Alpha
Pullan Consulting
QurAlis
ReadCube Papers
RedHill Biopharma
REGENXBIO
Rejuvenate Bio
Remedium Bio, Inc.
Remiges Ventures, Inc.
Resurge Therapeutics
Ropes & Gray
Rubedo Life Sciences
Russo Partners
Salarius Pharma
Sampling Human, Inc.
Sandhill Angels
Santen, Inc.
SaponiQx
Science37
Scientific American
SD Asset Management
SeedFolio
Shaw Strategic Capital LLC
shinyusha Publishing
Sidereal Therapeutics
Silicon Valley Bank
SimBioSys, Inc.
Simonovation, LLC
Singh Biotechnology
Sixth Borough Capital Management
Society for Brain Mapping & Therapeutics
Sofinnova Partners
South Dakota Biotech
Special Situations Funds
Spencer Paige Corporation
Sphere Health
Stanford University’s MediaX Program
Starton Therapeutics
StartUp Health
STAT
Strand Therapeutics
Surrey Capital Partners
Takeda Pharmaceuticals
Talentmark
Tectonic Capital
Teijin Pharma
Telegraph Hill Partners
Telix Pharmaceuticals
TeselaGen Biotechnology, Inc.
The Chopra Foundation
The rebel group
The Rockefeller Foundation
The Trip Report
ThinkEquity
Third Pole Therapeutics
Thrive Bioscience, Inc.
Tiberend Strategic Advisors, Inc.
Todos Medical
Tonic BIoventures
Torch Capital
Torreya
TransPacific Venture Capital Partners
TrialSpark
Tryl
Two Bear Capital
UC San Francisco
University of Massachusetts Amherst
US Department of Veterans Affairs
V2M Capital
Valhalla Therapeutics Inc.
Venture Valuation INC.
ViCardia Therapeutics Inc.
Vigene Biosciences
Vine Ventures
Viva BioInnovator
WARF Ventures
WBB Securities LLC
WinSanTor
Within Health, LLC
Xora Innovation
Yale University School of Medicine & Bioethics Int
Yonjin Venture LLC
Yunion Healthcare Fund
Zimmons International Communications